Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Tenax Therapeutics (TENX) Equity Ratio (2016 - 2026)

Tenax Therapeutics' Equity Ratio history spans 6 years, with the latest figure at 0.9 for Q4 2017.

  • On a quarterly basis, Equity Ratio rose 22.28% to 0.9 in Q4 2017 year-over-year; TTM through Dec 2017 was 0.9, a 22.28% increase, with the full-year FY2017 number at 0.9, up 22.28% from a year prior.
  • Equity Ratio hit 0.9 in Q4 2017 for Tenax Therapeutics, down from 0.92 in the prior quarter.
  • Over the last five years, Equity Ratio for TENX hit a ceiling of 0.92 in Q3 2017 and a floor of 0.56 in Q2 2013.
  • Historically, Equity Ratio has averaged 0.54 across 4 years, with a median of 0.79 in 2016.
  • Biggest five-year swings in Equity Ratio: plummeted 569.11% in 2013 and later increased 22.28% in 2017.
  • Tracing TENX's Equity Ratio over 4 years: stood at 0.56 in 2013, then soared by 248.09% to 0.83 in 2015, then dropped by 11.29% to 0.73 in 2016, then increased by 22.28% to 0.9 in 2017.
  • Business Quant data shows Equity Ratio for TENX at 0.9 in Q4 2017, 0.92 in Q3 2017, and 0.84 in Q2 2017.